41 – 50 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
- Contribution to journal › Article
-
Mark
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
- Contribution to journal › Article
-
Mark
Current status of clinical proteogenomics in lung cancer
- Contribution to journal › Scientific review
-
Mark
Comparison between silicon photomultiplier-based and conventional PET/CT in patients with suspected lung cancer—a pilot study
- Contribution to journal › Article
- 2018
-
Mark
Epithelial–mesenchymal transition, a spectrum of states : Role in lung development, homeostasis, and disease
- Contribution to journal › Scientific review
-
Mark
It is important that the process goes quickly, isn't it?” A qualitative multi-country study of colorectal or lung cancer patients’ narratives of the timeliness of diagnosis and quality of care
- Contribution to journal › Article
-
Mark
Complement C4d-specific antibodies for the diagnosis of lung cancer
- Contribution to journal › Article
-
Mark
Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
- Contribution to journal › Article
-
Mark
Genomic characterization of non-small cell lung cancer - clinical and molecular implications
- Thesis › Doctoral thesis (compilation)
